WebbDescription. T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM in a cell-free assay, with a >800-fold selectivity over PPARα and PPARδ. T0070907 … Webb10 juni 2016 · Cell cycle progression is tightly regulated by the cyclin family proteins, cyclin-dependent kinases (CDKs) and CDK inhibitors. A major player in G1 progression is the …
National Center for Biotechnology Information
WebbChk2 Inhibitor II (BML-277) is an ATP-competitive inhibitor of Chk2 with IC50 of 15 nM. It is 1000-fold more selective toward Chk2 serine/threonine kinase than for Chk1 and Cdk1/B kinases. Chk2 Inhibitor II (BML-277) dose dependently protects human CD4 (+) and CD8 (+) T-cells from apoptosis due to ionizing radiation. CAS No. 516480-79-8 WebbBiochem/physiol Actions. Isozyme selective Akt1/2 kinase inhibitor. In in vitro kinase assays, Akt1/2 kinase inhibitor shows IC 50 = 58 nM, 210 nM, and 2.12 mM for Akt1, … heart health park capacity
USP7 limits CDK1 activity throughout the cell cycle
WebbBioAssay record AID 1301366 submitted by ChEMBL: Inhibition of MK2 in human U937 cells assessed as reduction in LPS-stimulated HSP27 phosphorylation at Ser82 … Webb4 feb. 2014 · Background The resistance of cancerous cells to chemotherapy remains the main limitation for cancer treatment at present. Doxorubicin (DOX) is a potent antitumor … WebbThe cyclin-dependent kinase (Cdk) inhibitor p27 regulates cell proliferation, cell motility and apoptosis, and is inactivated through various means in many types of human … mount fako